
Bristol Myers Squibb
Global biopharmaceutical company researching and delivering medicines in oncology, hematology, neuroscience, immunology and cardiovascular care.
About Bristol Myers Squibb
A global biopharmaceutical company
Bristol Myers Squibb discovers, develops and delivers medicines for patients with serious diseases. Its work spans research and development, a marketed medicines portfolio and medical resources for healthcare professionals and patients.
Therapeutic areas
- Oncology: treatment of solid tumors.
- Hematology: therapies across blood diseases with high unmet need.
- Neuroscience: disease-modifying and symptomatic therapies for neurological and psychiatric conditions.
- Immunology: solutions for dermatology, gastroenterology, pulmonology and rheumatology.
- Cardiovascular: research building on a 70-year legacy of cardiovascular medicines.
Pipeline
As of October 29, 2026, the company reports 49 compounds in development across more than 40 disease areas, targeting areas where it aims to deliver transformative medicines.
Corporate information and inquiries
The corporate headquarters are listed at Route 206 & Province Line Road, Princeton, New Jersey. The company maintains separate channels for customer and community relations, medical information, side-effect and product-quality reporting, media relations, investor relations and compliance concerns. Its Integrity Line is a confidential telephone and web-based reporting system hosted by Navex Global. EQ Shareowner Services acts as transfer agent for directly registered stock.
Biopharmaceutical research and medicines
Photos
Select a photo to enlarge it.

